Premalignant Disorders
Oral Submucous Fibrosis
aka OSMF
Chronic, progressive, scarring disease of oral mucosa strongly associated with areca nut chewing; a WHO-recognised potentially malignant disorder.
§ figuresFigures (1)
Fig. 1Generalized submucous fibrosis of oral cavity
“Oral submucous fibrosis” · Saivishnu.ponnapalli · CC BY-SA 4.0 · Wikimedia Commons
Verified open-access images only, reproduced for education under their stated licences · no AI-generated or illustrative artwork · Oral Submucous Fibrosis figures pending faculty review.
§ overviewOverview
Chronic, progressive, scarring disease of oral mucosa strongly associated with areca nut chewing; a WHO-recognised potentially malignant disorder.
§ etiologyEtiology
- 01Areca nut (arecoline)
- 02Capsaicin
- 03Nutritional deficiencies
- 04Genetic predisposition (HLA-A10, DR3, DR7)
§ epidemiologyEpidemiology
Highest prevalence in Indian subcontinent. Young adults.
§ pathogenesisPathogenesis
Arecoline stimulates fibroblast proliferation & collagen synthesis, reduces collagen degradation, and increases TGF-β.
§ clinicalClinical Features
- 01Burning sensation, especially with spicy food
- 02Blanched marble-like mucosa
- 03Palpable vertical fibrous bands
- 04Progressive trismus
- 05Depapillation of tongue
§ histopathHistopathology
- 01Early: juxtaepithelial oedema and hyalinisation
- 02Advanced: dense hyalinised collagen bundles, atrophic epithelium, epithelial dysplasia
§ classificationClassification
- 01Khanna & Andrade (I–IVB) — clinical + histopathologic
- 02Pindborg staging (Stage 1–3)
§ treatmentTreatment
- 01Habit cessation (mandatory)
- 02Intralesional steroids ± hyaluronidase
- 03Placental extract injection, pentoxifylline, lycopene
- 04Surgical release of fibrous bands + reconstruction (buccal fat pad, nasolabial flap) for severe trismus
- 05Physiotherapy — mouth-opening exercises
§ prognosisPrognosis
Malignant transformation 7–13%.
§ preventionPrevention
- 01Public health campaigns against areca/pan masala use
§ pearlsClinical Pearls
- 01OSMF is irreversible — early diagnosis is critical.
§ mcqsMCQs — Assessment (1)
Question 1
Principal aetiological agent of OSMF:
§ evidenceReferences & Evidence
Current Classification
WHO Classification of Tumours Online — Head and Neck
IARC / WHO · 2022
Continuously updated online edition of the WHO head and neck tumour classification.
Evidence summary
Highest level of evidence linked to this page: WHO / Official Classification.
- L1 · Classification — 1
- L2 · Guideline — 1
- L6 · Textbook — 3
1 linked source was published from 2024 onwards. Where guidance is limited or contested, rely on the higher-level sources above rather than this summary. Educational use only — not a substitute for clinical judgement.
Content last reviewed
September 2026
Evidence last reviewed
September 2026
Next scheduled review
September 2027
Review status
EVIDENCE REVIEWED
Search latest PubMed evidence
Last literature search: 7 September 2026
Current Classification
IARC / WHO. IARC · 2022
Continuously updated online edition of the WHO head and neck tumour classification.
Clinical Guidelines
Warnakulasuriya S, Kujan O, Aguirre-Urizar JM et al.. Oral diseases · 2021 · 27(8):1862-1880
WHO collaborating centre consensus on nomenclature and classification of oral potentially malignant disorders.
Histopathology References
Barnes L. CRC Press · 2008
Detailed histopathological reference for head and neck diagnostic criteria.
Textbook References
Neville BW, Damm DD, Allen CM et al.. Elsevier · 2024
Standard reference textbook of oral and maxillofacial pathology used throughout this atlas.
Rajendran R, Sivapathasundharam B. Elsevier · 2020
Undergraduate and postgraduate oral pathology textbook widely used in BDS and FCPS curricula.
Draft — pending faculty review. Educational use only; verify against current guidelines and primary sources before clinical application.